Molecular Devices and Biolog are collaborating to explore how the QPix FLEX Microbial Colony Picking System inside the Biolog AS-500 anaerobic chamber can streamline microbial sample handling while maintaining conditions for biology.
Published
Signal category
Products & Services
Quote
“Join Sheela Muley, Product Manager, Biopharma at Molecular Devices, and Max Cravener, Ph.D., Product Manager, Instruments & Software at Biolog, as they explore how the QPix® FLEX™ Microbial Colony Picking System inside the Biolog AS-500 anaerobic chamber can help streamline microbial sample handling while maintaining the conditions your biology demands.”
— Molecular Devices team
Company
Molecular Devices
Advancing Discovery
- Industry
- Biotechnology Research
- Location
- San Jose, US
- Company size
- 725 employees
Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over 1,000 associates are guided by our diverse leadership team and female president that prioritize a culture of collaboration, engagement, diversity, and inclusion. Molecular Devices is proud to be part of Danaher, a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. As part of Danaher, Molecular Devices is connected to a uniquely broad ecosystem of expertise, technologies, and capabilities. Together, we partner closely with customers to help solve their toughest challenges with greater speed and certainty. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.
Founded 1983